Source and scope
This summary is bounded to the recommendations, population and decisions covered by Family-Centred Maternity and Newborn Care: Chapter 2 — Preconception Care. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:PHAC preconception care
Source-attributed clinical priorities
- Review pregnancy intentions, medicines, chronic disease, immunization, genetic and infection risk, substance use and social safety.
- Optimize folate, nutrition and disease control and replace teratogenic medicines before conception when a safe alternative exists.
- Refer high-risk cardiac, renal, endocrine, neurologic, genetic or prior obstetric conditions before pregnancy.
- Ask about pregnancy intention routinely so medicine and disease optimization can occur before conception.
sources for this section:PHAC preconception care
Practical assessment and management workflow
1
Review chronic conditions, obstetric history, medicines, supplements, vaccines, infections, genetics and substance use.
2
Measure relevant disease control and replace teratogenic medicine with a safe effective alternative.
3
Recommend folic acid and nutrition appropriate to Canadian risk and address dental and mental health.
4
Connect high-risk conditions to maternal-fetal medicine, genetics or specialty care before pregnancy.
sources for this section:PHAC preconception care
Safety, red flags and urgent escalation
- Do not stop essential medicine abruptly without a replacement and relapse plan.
- Live vaccines require appropriate timing before conception.
- Active violence, severe substance instability or uncontrolled disease requires coordinated safety and medical support.
sources for this section:PHAC preconception care
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:PHAC preconception care
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:PHAC preconception care
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Public Health Agency of CanadaFamily-Centred Maternity and Newborn Care: Chapter 2 — Preconception Careaccessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.